BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35370098)

  • 1. Medicaid expansion is associated with a higher likelihood of early diagnosis, resection, transplantation, and overall survival in patients with hepatocellular carcinoma.
    Elshami M; Hoehn R; Hue JJ; Rothermel L; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 Sep; 24(9):1482-1491. PubMed ID: 35370098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care.
    Lima HA; Endo Y; Moazzam Z; Alaimo L; Dillhoff M; Kim A; Beane J; Ejaz A; Cloyd J; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Aug; 30(8):4589-4599. PubMed ID: 37142835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.
    Lee GC; Ferrone CR; Vagefi PA; Uppot RN; Tanabe KK; Lillemoe KD; Blaszkowsky LS; Qadan M
    Am J Surg; 2019 Jul; 218(1):157-163. PubMed ID: 30635211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Sociodemographic Factors with Surgical Management of Hepatoblastoma and Hepatocellular Carcinoma in Children.
    Ziogas IA; Roach JP; Acker SN; Corkum KS; Diaz-Miron JL; Kulungowski AM; Gosain A; Hills-Dunlap JL
    J Pediatr; 2024 Jun; 269():113963. PubMed ID: 38369237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
    Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicaid expansion and palliative care for advanced-stage liver cancer.
    Lima HA; Mavani P; Munir MM; Endo Y; Woldesenbet S; Khan MMM; Rawicz-Pruszyński K; Waqar U; Katayama E; Resende V; Khalil M; Pawlik TM
    J Gastrointest Surg; 2024 Apr; 28(4):434-441. PubMed ID: 38583893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal survival benefit in the treatment of early hepatocellular carcinoma.
    Midorikawa Y; Takayama T; Shimada K; Nakayama H; Higaki T; Moriguchi M; Nara S; Tsuji S; Tanaka M
    J Hepatol; 2013 Feb; 58(2):306-11. PubMed ID: 23063418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma.
    Rasic G; de Geus SWL; Papageorge MV; Woods AP; Ng SC; McAneny D; Tseng JF; Sachs TE
    World J Surg; 2023 Jul; 47(7):1780-1789. PubMed ID: 36918443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond insurance status: the impact of Medicaid expansion on the diagnosis of Hepatocellular Carcinoma.
    Papageorge MV; Woods AP; de Geus SWL; Ng SC; Paasche-Orlow MK; Segev D; McAneny D; Kenzik KM; Sachs TE; Tseng JF
    HPB (Oxford); 2022 Aug; 24(8):1271-1279. PubMed ID: 35042672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
    Yang JD; Luu M; Singal AG; Noureddin M; Kuo A; Ayoub WS; Sundaram V; Kotler H; Kim IK; Todo T; Voidonikolas G; Brennan TV; Kosari K; Klein AS; Hendifar A; Lu SC; Nissen NN; Gong J
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1210-1220. PubMed ID: 32886898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
    Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
    J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
    Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
    Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
    Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
    Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis.
    Kim EJ; Ganga A; Lee JY; Zawadzki RS; Adriance W; Wang R; Cholankeril G; Somasundar PS
    Eur J Surg Oncol; 2023 Apr; 49(4):794-801. PubMed ID: 36503726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.